img

Global Leber's Hereditary Optic Neuropathy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Leber's Hereditary Optic Neuropathy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Leber's Hereditary Optic Neuropathy Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leber's Hereditary Optic Neuropathy Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Leber's Hereditary Optic Neuropathy Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Leber's Hereditary Optic Neuropathy Drug key manufacturers include Alkeus Pharmaceuticals, Inc., Biovista Inc., GenSight Biologics S.A., Ixchel Pharma, LLC, Khondrion BV, Spark Therapeutics, Inc. and Stealth BioTherapeutics Inc., etc. Alkeus Pharmaceuticals, Inc., Biovista Inc., GenSight Biologics S.A. are top 3 players and held % sales share in total in 2022.
Leber's Hereditary Optic Neuropathy Drug can be divided into Elamipretide, GS-011, IXC-201 and KH-176, etc. Elamipretide is the mainstream product in the market, accounting for % sales share globally in 2022.
Leber's Hereditary Optic Neuropathy Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Leber's Hereditary Optic Neuropathy Drug industry development. In 2022, global % sales of Leber's Hereditary Optic Neuropathy Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leber's Hereditary Optic Neuropathy Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc.
Segment by Type
Elamipretide
GS-011
IXC-201
KH-176
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Leber's Hereditary Optic Neuropathy Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leber's Hereditary Optic Neuropathy Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leber's Hereditary Optic Neuropathy Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Leber's Hereditary Optic Neuropathy Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leber's Hereditary Optic Neuropathy Drug introduction, etc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Leber's Hereditary Optic Neuropathy Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Leber's Hereditary Optic Neuropathy Drug Market Overview
1.1 Leber's Hereditary Optic Neuropathy Drug Product Overview
1.2 Leber's Hereditary Optic Neuropathy Drug Market Segment by Type
1.2.1 Elamipretide
1.2.2 GS-011
1.2.3 IXC-201
1.2.4 KH-176
1.2.5 Others
1.3 Global Leber's Hereditary Optic Neuropathy Drug Market Size by Type
1.3.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Leber's Hereditary Optic Neuropathy Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Type (2018-2024)
2 Global Leber's Hereditary Optic Neuropathy Drug Market Competition by Company
2.1 Global Top Players by Leber's Hereditary Optic Neuropathy Drug Sales (2018-2024)
2.2 Global Top Players by Leber's Hereditary Optic Neuropathy Drug Revenue (2018-2024)
2.3 Global Top Players by Leber's Hereditary Optic Neuropathy Drug Price (2018-2024)
2.4 Global Top Manufacturers Leber's Hereditary Optic Neuropathy Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Leber's Hereditary Optic Neuropathy Drug Market Competitive Situation and Trends
2.5.1 Leber's Hereditary Optic Neuropathy Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leber's Hereditary Optic Neuropathy Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Leber's Hereditary Optic Neuropathy Drug Market
2.8 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Leber's Hereditary Optic Neuropathy Drug Status and Outlook by Region
3.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Region
3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Sales in Value by Region (2018-2024)
3.2.3 Global Leber's Hereditary Optic Neuropathy Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Region
3.3.1 Global Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Leber's Hereditary Optic Neuropathy Drug Sales in Value by Region (2024-2034)
3.3.3 Global Leber's Hereditary Optic Neuropathy Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Leber's Hereditary Optic Neuropathy Drug by Application
4.1 Leber's Hereditary Optic Neuropathy Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Leber's Hereditary Optic Neuropathy Drug Market Size by Application
4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Breakdown by Application (2018-2024)
5 North America Leber's Hereditary Optic Neuropathy Drug by Country
5.1 North America Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Country
5.1.1 North America Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2018-2024)
5.2 North America Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Country
5.2.1 North America Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2024-2034)
6 Europe Leber's Hereditary Optic Neuropathy Drug by Country
6.1 Europe Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Country
6.1.1 Europe Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2018-2024)
6.2 Europe Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Country
6.2.1 Europe Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug by Region
7.1 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Region
7.1.1 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales in Value by Region (2024-2034)
8 Latin America Leber's Hereditary Optic Neuropathy Drug by Country
8.1 Latin America Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Country
8.1.1 Latin America Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2018-2024)
8.2 Latin America Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Country
8.2.1 Latin America Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug by Country
9.1 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Historic Market Size by Country
9.1.1 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alkeus Pharmaceuticals, Inc.
10.1.1 Alkeus Pharmaceuticals, Inc. Company Information
10.1.2 Alkeus Pharmaceuticals, Inc. Introduction and Business Overview
10.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Products Offered
10.1.5 Alkeus Pharmaceuticals, Inc. Recent Development
10.2 Biovista Inc.
10.2.1 Biovista Inc. Company Information
10.2.2 Biovista Inc. Introduction and Business Overview
10.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Products Offered
10.2.5 Biovista Inc. Recent Development
10.3 GenSight Biologics S.A.
10.3.1 GenSight Biologics S.A. Company Information
10.3.2 GenSight Biologics S.A. Introduction and Business Overview
10.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Products Offered
10.3.5 GenSight Biologics S.A. Recent Development
10.4 Ixchel Pharma, LLC
10.4.1 Ixchel Pharma, LLC Company Information
10.4.2 Ixchel Pharma, LLC Introduction and Business Overview
10.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Products Offered
10.4.5 Ixchel Pharma, LLC Recent Development
10.5 Khondrion BV
10.5.1 Khondrion BV Company Information
10.5.2 Khondrion BV Introduction and Business Overview
10.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Products Offered
10.5.5 Khondrion BV Recent Development
10.6 Spark Therapeutics, Inc.
10.6.1 Spark Therapeutics, Inc. Company Information
10.6.2 Spark Therapeutics, Inc. Introduction and Business Overview
10.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Products Offered
10.6.5 Spark Therapeutics, Inc. Recent Development
10.7 Stealth BioTherapeutics Inc.
10.7.1 Stealth BioTherapeutics Inc. Company Information
10.7.2 Stealth BioTherapeutics Inc. Introduction and Business Overview
10.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Products Offered
10.7.5 Stealth BioTherapeutics Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Leber's Hereditary Optic Neuropathy Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Leber's Hereditary Optic Neuropathy Drug Industrial Chain Analysis
11.4 Leber's Hereditary Optic Neuropathy Drug Market Dynamics
11.4.1 Leber's Hereditary Optic Neuropathy Drug Industry Trends
11.4.2 Leber's Hereditary Optic Neuropathy Drug Market Drivers
11.4.3 Leber's Hereditary Optic Neuropathy Drug Market Challenges
11.4.4 Leber's Hereditary Optic Neuropathy Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Leber's Hereditary Optic Neuropathy Drug Distributors
12.3 Leber's Hereditary Optic Neuropathy Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Elamipretide
Table 2. Major Company of GS-011
Table 3. Major Company of IXC-201
Table 4. Major Company of KH-176
Table 5. Major Company of Others
Table 6. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Leber's Hereditary Optic Neuropathy Drug Market Share in Value by Type (2018-2024)
Table 11. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Leber's Hereditary Optic Neuropathy Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Company (2018-2024)
Table 29. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Leber's Hereditary Optic Neuropathy Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Leber's Hereditary Optic Neuropathy Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leber's Hereditary Optic Neuropathy Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Leber's Hereditary Optic Neuropathy Drug Market
Table 36. Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Leber's Hereditary Optic Neuropathy Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Alkeus Pharmaceuticals, Inc. Company Information
Table 111. Alkeus Pharmaceuticals, Inc. Introduction and Business Overview
Table 112. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product
Table 114. Alkeus Pharmaceuticals, Inc. Recent Development
Table 115. Biovista Inc. Company Information
Table 116. Biovista Inc. Introduction and Business Overview
Table 117. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product
Table 119. Biovista Inc. Recent Development
Table 120. GenSight Biologics S.A. Company Information
Table 121. GenSight Biologics S.A. Introduction and Business Overview
Table 122. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product
Table 124. GenSight Biologics S.A. Recent Development
Table 125. Ixchel Pharma, LLC Company Information
Table 126. Ixchel Pharma, LLC Introduction and Business Overview
Table 127. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product
Table 129. Ixchel Pharma, LLC Recent Development
Table 130. Khondrion BV Company Information
Table 131. Khondrion BV Introduction and Business Overview
Table 132. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product
Table 134. Khondrion BV Recent Development
Table 135. Spark Therapeutics, Inc. Company Information
Table 136. Spark Therapeutics, Inc. Introduction and Business Overview
Table 137. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product
Table 139. Spark Therapeutics, Inc. Recent Development
Table 140. Stealth BioTherapeutics Inc. Company Information
Table 141. Stealth BioTherapeutics Inc. Introduction and Business Overview
Table 142. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product
Table 144. Stealth BioTherapeutics Inc. Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Leber's Hereditary Optic Neuropathy Drug Market Trends
Table 148. Leber's Hereditary Optic Neuropathy Drug Market Drivers
Table 149. Leber's Hereditary Optic Neuropathy Drug Market Challenges
Table 150. Leber's Hereditary Optic Neuropathy Drug Market Restraints
Table 151. Leber's Hereditary Optic Neuropathy Drug Distributors List
Table 152. Leber's Hereditary Optic Neuropathy Drug Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Leber's Hereditary Optic Neuropathy Drug Product Picture
Figure 2. Global Leber's Hereditary Optic Neuropathy Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Leber's Hereditary Optic Neuropathy Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Leber's Hereditary Optic Neuropathy Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Elamipretide
Figure 6. Global Elamipretide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of GS-011
Figure 8. Global GS-011 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of IXC-201
Figure 10. Global IXC-201 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of KH-176
Figure 12. Global KH-176 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Leber's Hereditary Optic Neuropathy Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Leber's Hereditary Optic Neuropathy Drug Revenue in 2022
Figure 29. Leber's Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Leber's Hereditary Optic Neuropathy Drug Manufacturing Cost Structure
Figure 49. Leber's Hereditary Optic Neuropathy Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries